US 10519139
Polymorphs of Selinexor
granted A61KA61K31/497A61P
Quick answer
US patent 10519139 (Polymorphs of Selinexor) held by Karyopharm Therapeutics Inc. expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Karyopharm Therapeutics Inc.
- Grant date
- Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/497, A61P, A61P35/00